drugset / Trial / NCT05895266
A Study to Assess Drug-Drug Interaction Between ABBV-903 and Midazolam in Adult Healthy Volunteers
Non-randomizedSequentialOpen-labelTreatment
Summary
The main objective of this study is to assess the drug-drug interaction and pharmacokinetics of ABBV-903 and Midazolam in healthy adult participants.
Timeline
- Start
- 2023-06-23
- Primary completion
- 2023-11-02
- Completion
- 2023-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-903 | Unknown | 200 mg | Oral |
| Subject | ABBV-903 | Unknown | 400 mg | Oral |
| Subject | Midazolam | Small molecule | 1 mg | Oral |
Indications
No indication recorded.